Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis

REFERENCES

• Meyer N, Penn LZ. 2008. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8:976–990.
   PubMed Web of Science ®Google Scholar
• Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. 2004. Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 4:562–568.
   PubMedGoogle Scholar
• Kleine-Kohlbrecher D, Adhikary S, Eilers M. 2006. Mechanisms of transcriptional repression by Myc. Curr. Top. Microbiol. Immunol. 302:51–62.
   PubMed Web of Science ®Google Scholar
• Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B. 2003. Genomic targets of the human c-Myc protein. Genes Dev. 17:1115–1129.
   PubMed Web of Science ®Google Scholar
• Flinn EM, Busch CM, Wright AP. 1998. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol. 18:5961–5969.
   PubMed Web of Science ®Google Scholar
• Jones TR, Cole MD. 1987. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′ untranslated sequences. Mol. Cell. Biol. 7:4513–4521.
   PubMed Web of Science ®Google Scholar
• Kelly K, Cochran BH, Stiles CD, Leder P. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Sears R, Leone G, DeGregori J, Nevins JR. 1999. Ras enhances Myc protein stability. Mol. Cell 3:169–179.
   PubMed Web of Science ®Google Scholar
• Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, Tokarz S, Morgan C, Sears RC. 2009. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J. 28:500–512.
   PubMed Web of Science ®Google Scholar
• Lutterbach B, Hann SR. 1994. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol. 14:5510–5522.
   PubMed Web of Science ®Google Scholar
• Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR. 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59–70.
   PubMed Web of Science ®Google Scholar
• Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2501–2514.
   PubMed Web of Science ®Google Scholar
• Bachireddy P, Bendapudi PK, Felsher DW. 2005. Getting at MYC through RAS. Clin. Cancer Res. 11:4278–4281.
   PubMedGoogle Scholar
• Sears RC. 2004. The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3:1133–1137.
   PubMed Web of Science ®Google Scholar
• Bechard M, Dalton S. 2009. Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal. Mol. Cell. Biol. 29:2092–2104.
   PubMedGoogle Scholar
• Gregory MA, Qi Y, Hann SR. 2003. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 278:51606–51612.
   PubMed Web of Science ®Google Scholar
• Arnold HK, Sears RC. 2006. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol. Cell. Biol. 26:2832–2844.
   PubMed Web of Science ®Google Scholar
• Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. 2004. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6:308–318.
   PubMed Web of Science ®Google Scholar
• Amati B. 2004. Myc degradation: dancing with ubiquitin ligases. Proc. Natl. Acad. Sci. U. S. A. 101:8843–8844.
   PubMedGoogle Scholar
• Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE. 2004. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. U. S. A. 101:9085–9090.
   PubMed Web of Science ®Google Scholar
• Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. 2004. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23:2116–2125.
   PubMed Web of Science ®Google Scholar
• Malempati S, Tibbitts D, Cunningham M, Akkari Y, Olson S, Fan G, Sears RC. 2006. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. Leukemia 20:1572–1581.
   PubMedGoogle Scholar
• Zhang X, Farrell AS, Daniel CJ, Arnold H, Scanlan C, Laraway BJ, Janghorban M, Lum L, Chen D, Troxell M, Sears R. 2012. Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. Proc. Natl. Acad. Sci. U. S. A. 109:2790–2795.
   PubMed Web of Science ®Google Scholar
• Ryo A, Liou YC, Lu KP, Wulf G. 2003. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 116:773–783.
   PubMed Web of Science ®Google Scholar
• Yeh ES, Means AR. 2007. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 7:381–388.
   PubMed Web of Science ®Google Scholar
• Rustighi A, Tiberi L, Soldano A, Napoli M, Nuciforo P, Rosato A, Kaplan F, Capobianco A, Pece S, Di Fiore PP, Del Sal G. 2009. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 11:133–142.
   PubMedGoogle Scholar
• Takahashi K, Akiyama H, Shimazaki K, Uchida C, Akiyama-Okunuki H, Tomita M, Fukumoto M, Uchida T. 2007. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 26:3835–3845.
   PubMedGoogle Scholar
• Yi P, Wu RC, Sandquist J, Wong J, Tsai SY, Tsai MJ, Means AR, O'Malley BW. 2005. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell. Biol. 25:9687–9699.
   PubMedGoogle Scholar
• Sears R, Ohtani K, Nevins JR. 1997. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol. 17:5227–5235.
   PubMedGoogle Scholar
• Escamilla-Powers JR, Sears RC. 2007. A conserved pathway that controls c-Myc protein stability through opposing phosphorylation events occurs in yeast. J. Biol. Chem. 282:5432–5442.
   PubMedGoogle Scholar
• Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, Loh YH, Yeo HC, Yeo ZX, Narang V, Govindarajan KR, Leong B, Shahab A, Ruan Y, Bourque G, Sung WK, Clarke ND, Wei CL, Ng HH. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133:1106–1117.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee JH, Iyer VR. 2008. Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One 3:e1798. doi:10.1371/journal.pone.0001798.
   PubMed Web of Science ®Google Scholar
• Abadie A. 2002. Bootstrap tests for distributional treatment effects in instrumental variable models. J. Am. Stat. Assoc. 97:284–292.
   Web of Science ®Google Scholar
• Sekhon J. 2011. Multivariate and propensity score matching software with automated balance optimization. J. Stat. Software. 42:1–52.
   Web of Science ®Google Scholar
• Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS. 2009. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27:1160–1167.
   PubMed Web of Science ®Google Scholar
• Molinari E, Gilman M, Natesan S. 1999. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 18:6439–6447.
   PubMed Web of Science ®Google Scholar
• Salghetti SE, Muratani M, Wijnen H, Futcher B, Tansey WP. 2000. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci. U. S. A. 97:3118–3123.
   PubMed Web of Science ®Google Scholar
• Thomas D, Tyers M. 2000. Transcriptional regulation: kamikaze activators. Curr. Biol. 10:R341–R343.
   PubMed Web of Science ®Google Scholar
• Uchida T, Takamiya M, Takahashi M, Miyashita H, Ikeda H, Terada T, Matsuo Y, Shirouzu M, Yokoyama S, Fujimori F, Hunter T. 2003. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 10:15–24.
   PubMedGoogle Scholar
• Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, Tyner AL. 2001. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. U. S. A. 98:4510–4515.
   PubMed Web of Science ®Google Scholar
• Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Moroy T, Bartek J, Massague J, Hanel F, Eilers M. 2001. Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3:392–399.
   PubMed Web of Science ®Google Scholar
• Liu T, Huang Y, Likhotvorik RI, Keshvara L, Hoyt DG. 2008. Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells. Am. J. Physiol. Cell Physiol. 295:C819–C827.
   PubMedGoogle Scholar
• Winkler KE, Swenson KI, Kornbluth S, Means AR. 2000. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287:1644–1647.
   PubMedGoogle Scholar
• Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. 1999. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 22:102–105.
   PubMed Web of Science ®Google Scholar
• Kenneth NS, Ramsbottom BA, Gomez-Roman N, Marshall L, Cole PA, White RJ. 2007. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc. Natl. Acad. Sci. U. S. A. 104:14917–14922.
   PubMed Web of Science ®Google Scholar
• Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M, Luscher B. 2003. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4:484–490.
   PubMed Web of Science ®Google Scholar
• Gargano B, Amente S, Majello B, Lania L. 2007. P-TEFb is a crucial co-factor for Myc transactivation. Cell Cycle 6:2031–2037.
   PubMed Web of Science ®Google Scholar
• Hebbes TR, Thorne AW, Crane-Robinson C. 1988. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7:1395–1402.
   PubMed Web of Science ®Google Scholar
• O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C, Hardwick J, Welcker M, Meijerink JP, Pieters R, Draetta G, Sears R, Clurman BE, Look AT. 2007. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 204:1813–1824.
   PubMed Web of Science ®Google Scholar
• Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Barrett JC, Weinstein JN. 2003. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4:R28.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Miller FR. 2000. Xenograft models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia 5:379–391.
   PubMed Web of Science ®Google Scholar
• Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. 2000. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 97:3444–3449.
   PubMed Web of Science ®Google Scholar
• Selbert S, Bentley DJ, Melton DW, Rannie D, Lourenco P, Watson CJ, Clarke AR. 1998. Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res. 7:387–396.
   PubMedGoogle Scholar
• Wang X, Cunningham M, Zhang X, Tokarz S, Laraway B, Troxell M, Sears RC. 2011. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. Cancer Res. 71:925–936.
   PubMedGoogle Scholar
• Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56–67.
   PubMed Web of Science ®Google Scholar
• Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D. 2008. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456:971–975.
   PubMed Web of Science ®Google Scholar
• Dang CV, Le A, Gao P. 2009. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 15:6479–6483.
   PubMed Web of Science ®Google Scholar
• van Riggelen J, Yetil A, Felsher DW. 2010. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10:301–309.
   PubMed Web of Science ®Google Scholar
• Giraud M, Yoshida H, Abramson J, Rahl PB, Young RA, Mathis D, Benoist C. 2012. Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 109:535–540.
   PubMedGoogle Scholar
• Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141:432–445.
   PubMed Web of Science ®Google Scholar
• Arabi A, Rustum C, Hallberg E, Wright AP. 2003. Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J. Cell Sci. 116:1707–1717.
   PubMedGoogle Scholar
• Luscher B, Vervoorts J. 2012. Regulation of gene transcription by the oncoprotein MYC. Gene 494:145–160.
   PubMed Web of Science ®Google Scholar
• Agrawal P, Yu K, Salomon AR, Sedivy JM. 2010. Proteomic profiling of Myc-associated proteins. Cell Cycle 9:4908–4921.
   PubMed Web of Science ®Google Scholar
• Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B. 2003. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4:575–580.
   PubMed Web of Science ®Google Scholar
• Sanchez-Arevalo Lobo VJ, Doni M, Verrecchia A, Sanulli S, Faga G, Piontini A, Bianchi M, Conacci-Sorrell M, Mazzarol G, Peg V, Losa JH, Ronchi P, Ponzoni M, Eisenman RN, Doglioni C, Amati B.14 January2013. Dual regulation of Myc by Abl. Oncogene. doi:10.1038/onc.2012.621.
   Google Scholar
• Dyson HJ, Wright PE. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6:197–208.
   PubMed Web of Science ®Google Scholar
• Fladvad M, Zhou K, Moshref A, Pursglove S, Safsten P, Sunnerhagen M. 2005. N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding. J. Mol. Biol. 346:175–189.
   PubMedGoogle Scholar
• Cowling VH, Cole MD. 2006. Mechanism of transcriptional activation by the Myc oncoproteins. Semin. Cancer Biol. 16:242–252.
   PubMed Web of Science ®Google Scholar
• Kim MR, Choi HS, Heo TH, Hwang SW, Kang KW. 2008. Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. Biochem. Biophys. Res. Commun. 369:547–553.
   PubMedGoogle Scholar
• Mantovani F, Piazza S, Gostissa M, Strano S, Zacchi P, Mantovani R, Blandino G, Del Sal G. 2004. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 14:625–636.
   PubMedGoogle Scholar
• Mantovani F, Tocco F, Girardini J, Smith P, Gasco M, Lu X, Crook T, Del Sal G. 2007. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat. Struct. Mol. Biol. 14:912–920.
   PubMed Web of Science ®Google Scholar
• Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP. 2003. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12:1413–1426.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Uchida C, Shin RW, Shimazaki K, Uchida T. 2008. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell. Mol. Life Sci. 65:359–375.
   PubMed Web of Science ®Google Scholar
• Lufei C, Koh TH, Uchida T, Cao X. 2007. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 26:7656–7664.
   PubMedGoogle Scholar
• Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11:695–707.
   PubMed Web of Science ®Google Scholar
• Lonard DM, Nawaz Z, Smith CL, O'Malley BW. 2000. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell 5:939–948.
   PubMed Web of Science ®Google Scholar
• Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP. 2001. Regulation of transcriptional activation domain function by ubiquitin. Science 293:1651–1653.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Spears E, Boone DN, Li Z, Gregory MA, Hann SR. 2013. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proc. Natl. Acad. Sci. U. S. A. 110:978–983.
   PubMedGoogle Scholar
• Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. 2003. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 63:6244–6251.
   PubMed Web of Science ®Google Scholar
• Lu KP. 2003. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4:175–180.
   PubMedGoogle Scholar
• Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW, Lu KP. 2002. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22:5281–5295.
   PubMed Web of Science ®Google Scholar
• Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, Lu KP. 2001. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20:3459–3472.
   PubMed Web of Science ®Google Scholar
• Lu KP, Hanes SD, Hunter T. 1996. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380:544–547.
   PubMed Web of Science ®Google Scholar
• Rippmann JF, Hobbie S, Daiber C, Guilliard B, Bauer M, Birk J, Nar H, Garin-Chesa P, Rettig WJ, Schnapp A. 2000. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ. 11:409–416.
   PubMedGoogle Scholar
• Wulf G, Ryo A, Liou YC, Lu KP. 2003. The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res. 5:76–82.
   PubMedGoogle Scholar
• Wulf G, Garg P, Liou YC, Iglehart D, Lu KP. 2004. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 23:3397–3407.
   PubMed Web of Science ®Google Scholar